Funding for this research was provided by:
American Health Assistance Foundation (A2007-096)
Deutsche Forschungsgemeinschaft (PI 379/8-1, PA930/12)
EU Joint Programme – Neurodegenerative Disease Research (PROP-AD: BMBF #01ED1605 - Germany)
Institute for Innovation through Science and Technology in Flanders (IWT-Vlaanderen)
Intramural Funding Program of the University Medical Center of the Johannes Gutenberg University Mainz
Foundation Alzheimer Research (SAO-FRMA 06601, ISAO 04602)
Text and Data Mining valid from 2019-04-19
Received: 23 January 2019
Accepted: 2 April 2019
First Online: 19 April 2019
Compliance with Ethical Standards
: The authors declare that they have no conflicts of interests. LP is a full employee of SANOFI, a pharmaceutical company, but he declares that he has no conflict of interest with regard to the present study.
: This article does not contain any studies with human participants performed by any of the authors.
: The research was approved by the Ethical Committees for Animal Experimentation of the KU Leuven and the Johannes Gutenberg University of Mainz and the ethical committee on animal care and use of Rhineland-Palatinate, Germany. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institutions or practice at which the studies were conducted.